Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology

Practical Radiation Oncology - Tập 1 - Trang 218-223 - 2011
Subir Nag1, D. Jeffrey Demanes2, Michael Hagan3, Mark J. Rivard4, Bruce R. Thomadsen5, James S. Welsh6, Jeffrey F. Williamson3
1Department of Radiation Oncology, Northern California Kaiser Permanente, Santa Clara, California
2Division of Brachytherapy, Department of Radiation Oncology, University of California Los Angeles, California
3Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia
4Department of Radiation Oncology, Tufts University School of Medicine, Boston, Massachusetts
5Departments of Medical Physics and Human Oncology, University of Wisconsin, Madison, Wisconsin
6Departments of Radiology, Neurosurgery and Radiation Oncology, LSU School of Medicine, and Willis-Knighton Hospital, Shreveport, Louisiana

Tài liệu tham khảo

Nath, 2009, AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137, Med Phys, 36, 5310, 10.1118/1.3246613 Tanaka, 2007, Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion, Int J Radiat Oncol Biol Phys, 69, 614, 10.1016/j.ijrobp.2007.05.082 Kucway, 2002, Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy, J Urol, 167, 2443, 10.1016/S0022-5347(05)65001-X McLaughlin, 2010, Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy, Int J Radiat Oncol Biol Phys, 76, 369, 10.1016/j.ijrobp.2009.02.019 Hoffelt, 2003, A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer, Int J Radiat Oncol Biol Phys, 57, 29, 10.1016/S0360-3016(03)00509-1 Crook, 2002, Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy, Brachytherapy, 1, 66, 10.1016/S1538-4721(02)00014-4 Lee, 2002, Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy, Int J Radiat Oncol Biol Phys, 54, 457, 10.1016/S0360-3016(02)02950-4 Gao, 2007, Effects of seed migration on post-implant dosimetry of prostate brachytherapy, Med Phys, 34, 471, 10.1118/1.2409748 Nag, 1999, American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer, Int J Radiat Oncol Biol Phys, 44, 789, 10.1016/S0360-3016(99)00069-3 Nag, 2000, The American Brachytherapy Society recommendations for permanent prostate brachytherapy post-implant dosimetric analysis, Int J Radiat Oncol Biol Phys, 46, 221, 10.1016/S0360-3016(99)00351-X Rivard, 2004, Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations, Med Phys, 31, 633, 10.1118/1.1646040 Hagan, 2011, Regulatory evaluation of prostate volume implants: pitfalls of a retrospective assessment, Brachytherapy, 10.1016/j.brachy.2011.01.005